ArticleScientific reports2022

RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.

Lei Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.